Awọn ile-iṣẹ Itọsọna

AI ni Ẹkọ aisan ara

Computational pathology applies image-analysis methods to digitized tissue slides.

Gbọ si itọsọna yiiAI-ṣe afihan · ~1 min

Lori iwe yi1 iseju kika
  1. Akopọ
  2. Jin Dive
  3. Real-World imuse
  4. Ojo iwaju ti AI ni Ẹkọ aisan ara
  5. Fifi o sinu iwa
  6. Tesiwaju Ṣiṣawari
  7. Awọn ibeere ti a beere nigbagbogbo

Akopọ

Whole-slide images are large, so models often process patches and combine patch-level evidence for slide-level tasks.

Jin Dive

The FDA De Novo review for Paige Prostate describes a computer-assisted pathology device that identifies suspicious areas on digitized prostate biopsy slides for pathologist review. CLAM is a research approach using attention-based multiple-instance learning for whole-slide classification with slide-level labels. Ki-67 is a cell-proliferation marker discussed in oncology. These tools and markers address specific tasks; their research or regulatory status does not generalize to every tissue, cancer or clinical decision.

Real-World imuse

A whole-slide image can be divided into tiles for model processing.

Multiple-instance learning can learn from slide-level labels when every patch is not individually annotated.

The FDA-reviewed Paige Prostate device assists pathologists with a specific prostate-biopsy review task.

Ki-67 is a protein marker used in assessing cell proliferation; an AI count is a measurement aid, not a standalone cancer diagnosis.

Ojo iwaju ti AI ni Ẹkọ aisan ara

Report the tissue type, scanner, population, reference standard and intended use when evaluating pathology AI. Keep pathologist oversight and assess performance across sites and specimen types. A clearance or benchmark for one device does not establish general clinical utility across pathology.

Fifi o sinu iwa

Kini idi ti o ṣe pataki

  • Ipo ati awọn ofin. Iyika ile-iṣẹ pinnu boya awọn imọran AI ye lọwọ olubasọrọ pẹlu otitọ.
  • Iṣakoso didara. Awọn ihamọ agbegbe ni ipa awọn oṣuwọn aṣiṣe itẹwọgba ati awọn awoṣe abojuto.
  • Kọ awọn yiyan. Awọn imuṣiṣẹ ti aṣeyọri ṣe deede agbara imọ-ẹrọ pẹlu ṣiṣan iṣẹ iwaju.

Ṣọra fun

  • Awọn ibeere ilana le jẹ alaiṣe bibẹẹkọ awọn apẹẹrẹ ti o lagbara.
  • Awọn data itan le ṣe koodu irẹjẹ ti o ṣe ipalara awọn agbegbe kan pato.
  • Awọn eto Legacy le ṣẹda awọn igo iṣọpọ ati awọn idiyele ti o farapamọ.

Next awọn igbesẹ

  1. Fi awọn amoye agbegbe wọle lati idasile iṣoro si igbelewọn.
  2. Awọn itọpa iṣayẹwo apẹrẹ ati awọn iwe aṣẹ ṣaaju ifilọlẹ.
  3. Ṣe ifọwọsi ibamu ati awọn adehun ailewu ni kutukutu.
  4. Yi lọ jade ni awọn ipele pẹlu ko o Duro ati rollback àwárí mu.

Tesiwaju Ṣiṣawari

Ìwé ìròyìn ọfẹ

Gba ìkànìyàn AI ojoojúmọ́

Ìtàn AI mẹta tó jẹ́rìí ní gbogbo owurọ́ ọjọ́ iṣẹ́, kọ́wé ní Gẹ̀ẹ́sì tó rọrùn. Ọfẹ́ fún gbogbo àkókò, kò sí ìpolówó.

Ìmeèlì kan ní gbogbo ọjọ́ iṣẹ́. Yọkúrò ní ìkànìyàn ní ìkànìyàn kan. A kò ta tàbí pín àdírẹ́sì rẹ.

Ṣe idanwo fun ara rẹ

Take the AI in Pathology quiz

Ìdáhùn lẹ́sẹ̀kẹsẹ̀ lórí gbogbo ìdáhùn, àti iwe-ẹ̀rí tó lè pin pẹ̀lú ID tó lè jẹ́rìí lẹ́yìn tí o bá kọ́ ẹ̀kọ́.

Bẹrẹ adanwo

Ṣe àtìlẹ́yìn ẹ̀kọ́ AI ọfẹ́. AI Understanding jẹ́ àjọ àìní èrè 501(c)(3) — kò sí ìpolówó, kò sí àkúnya owó, ní gbogbo àkókò. Ṣe ẹbun kan

Awọn ibeere ti a beere nigbagbogbo

Kini AI ni Pathology?

Computational pathology applies image-analysis methods to digitized tissue slides. Whole-slide images are large, so models often process patches and combine patch-level evidence for slide-level tasks.

Kini 'aworan ifaworanhan gbogbo' ni imọ-ọkan oni-nọmba?

Awọn ifaworanhan jẹ ti ṣayẹwo sinu awọn aworan gigapixel nla, nigbagbogbo awọn ọkẹ àìmọye awọn piksẹli, ti AI lẹhinna ṣe itupalẹ.

Kini idi ti awọn awoṣe AI ṣe ilana awọn ifaworanhan ni awọn alẹmọ kekere tabi awọn abulẹ?

Awọn aworan ifaworanhan ni o tobi ju fun titẹ sii awoṣe kan, nitorinaa wọn pin si ẹgbẹẹgbẹrun awọn alẹmọ ati awọn abajade ti tun darapọ.

What regulatory pathway did FDA use for Paige Prostate?

FDA’s DEN200080 record is a De Novo classification for a specific software device and intended use; the decision does not generalize to all pathology AI.

Kini iṣiro AI Ki-67 kan ninu tumo kan?

Ki-67 jẹ ami isamisi ti ilọsiwaju sẹẹli, ati kika awọn sẹẹli to dara tọkasi bi tumo ti n dagba ni ibinu.

What can an AI system provide in a pathology workflow, according to the scoped examples?

The cited FDA review describes a device intended to assist pathologists; its output is not a standalone diagnosis or treatment decision.